Sanlam Wealth rebrands to Atomos after £140m PE acquisition

The hybrid wealth manager’s name means ‘indivisible’ in ancient Greek

Jenna Brown
clock • 1 min read

Sanlam Wealth has rebranded to Atomos after it was acquired for £140m by funds managed by Oaktree Capital Management.

Sanlam UK sold the wealth management business to the private equity firm in September 2021. Atomos means ‘uncuttable' or ‘indivisible' in ancient Greek, according to the hybrid wealth manager. It said the business aimed to bring together all the "benefits of face-to-face service with the access and convenience of modern digital tools". In February this year, the firm announced changes to its leadership team with the exit of Sanlam Private Wealth chief executive Penny Lovell and new appointments including Haig Bathgate as head of investments, Niral Parekh as chief operating officer and...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Companies

PFS' Carla Brown: 'We've built a stronger, more constructive relationship with the CII'

PFS' Carla Brown: 'We've built a stronger, more constructive relationship with the CII'

Professional body has ‘come through some challenging years’

Isabel Baxter
clock 13 November 2025 • 2 min read
WH Ireland confirms takeover approach from Team

WH Ireland confirms takeover approach from Team

10 December deadline

Sahar Nazir
clock 13 November 2025 • 1 min read
FNZ raises $650m in funding from institutional shareholders

FNZ raises $650m in funding from institutional shareholders

Aviva, Aberdeen, and Nucleus part of backing

Isabel Baxter
clock 12 November 2025 • 1 min read